Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

DI-DIDA Digital Innovations and Diagnostics for Infectious Diseases in Africa

Coordinator
Innotrope SAS, France
Runs
1 October 2022 to 30 September 2027
Status
Running
EU funding
€6.5m
Total cost
€6.5m
Partners
16 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101057251

What the project is doing

In the project's own words, from its summary on CORDIS.

The DI-DIDA project's overall objective is to tackle poverty-related infectious diseases in sub-Saharan Africa and African islands by i) strengthening the African research capacities, ii) enhancing technology development in diagnostics and digital technologies in Africa, and iii) encouraging adoption of innovations by sub-Saharan health authorities, clinicians, businesses, and patients. For that, the consortium includes leading partners from four sub-Saharan African countries (Kenya, Senegal, Tanzania, and Uganda), one from African Islands (Réunion), and the EU.

To reach our objectives, we will implement a combination of complementary actions: - Joint research projects on infectious diseases co-morbidities, human-livestock interactions, infectious diseases diagnostic technologies, digital health solutions for Africa, and socio-economic factors of innovation adoption by African people. - The co-development of an innovative low-cost diagnostic and digital/mHealth decision support technology and its integration into existing African digital health infrastructure. - Clinical trials. - A PhD fellowship for students in Africa with joint PhD awarding by EU counterparts. - Research capacity building (management, grant writing, publications etc.) - Staff exchanges. - Training. - Organisation of citizen and brokerage events targeting businesses and policy makers. - A comprehensive dissemination, exploitation, and communication action plan.

The impact of this project will be: - Improved research / technology development and manufacturing /clinical trials capacities in sub-Saharan Africa. - New knowledge gained on several topics related with poverty-related infectious diseases. - Increased international networks and reinforcement of the collaboration between Africa and the EU. - A new low-cost diagnostics and decision support technology developed and its adoption fostered by dedicated studies and collaboration with health authorities. - Better informed sub-Saharan populations about infectious diseases.

Topics

Who is involved

OrganisationCityCountryRole
Innotrope SASOrsayFranceCoordinator
Institut PasteurParisFranceParticipant
Universite De La ReunionSaint Denis De La Reunion Cedex 9FranceParticipant
Istituto Nazionale Di Biostrutture E BiosistemiRomaItalyParticipant
Universita Degli Studi Di CataniaCataniaItalyThird party
African Population & Health Research Centre KenyaNairobiKenyaParticipant
Kenya Medical Research InstituteNairobiKenyaParticipant
Strathmore UniversityNairobiKenyaParticipant
Pharmaccess InternationalAmsterdamNetherlandsParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
Institut Pasteur De DakarDakarSNParticipant
The Good Samaritan FoundationMoshiTZParticipant
Ministry of HealthKampalaUGParticipant
Uganda National Health Research OrganisationEntebbeUGParticipant
Mologic LtdBedfordUnited KingdomAssociatedpartner
University of GlasgowGlasgowUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI